Authors:
Yarnell, JWG
Patterson, CC
Sweetnam, PM
Thomas, HF
Bainton, D
Elwood, PC
Bolton, CH
Miller, NE
Citation: Jwg. Yarnell et al., Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-upof caerphilly and speedwell cohorts, ART THROM V, 21(8), 2001, pp. 1340-1345
Authors:
Lowe, GDO
Yarnell, JWG
Rumley, A
Bainton, D
Sweetnam, PM
Citation: Gdo. Lowe et al., C-Reactive protein, fibrin D-dimer, and incident ischemic heart disease inthe speedwell study - Are inflammation and fibrin turnover linked in pathogenesis?, ART THROM V, 21(4), 2001, pp. 603-610
Citation: Gdo. Lowe et al., Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the Caerphilly Study, THROMB HAEM, 86(3), 2001, pp. 822-827
Authors:
Yarnell, JWG
Patterson, CC
Thomas, HF
Sweetnam, PM
Citation: Jwg. Yarnell et al., Central obesity: predictive value of skinfold measurements for subsequent ischaemic heart disease at 14 years follow-up in the Caerphilly Study, INT J OBES, 25(10), 2001, pp. 1546-1549
Authors:
Gaughan, DJ
Kluijtmans, LAJ
Barbaux, S
McMaster, D
Young, IS
Yarnell, JWG
Evans, A
Whitehead, AS
Citation: Dj. Gaughan et al., The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations, ATHEROSCLER, 157(2), 2001, pp. 451-456
Authors:
Yarnell, JWG
Sweetnam, PM
Rumley, A
Lowe, GDO
Citation: Jwg. Yarnell et al., Lifestyle and hemostatic risk factors for ischemic heart disease - The Caerphilly Study, ART THROM V, 20(1), 2000, pp. 271-279
Authors:
Strachan, DP
Carrington, D
Mendall, M
Butland, BK
Yarnell, JWG
Elwood, P
Citation: Dp. Strachan et al., Chlamydia pneumonia serology, lung function decline, and treatment for respiratory disease, AM J R CRIT, 161(2), 2000, pp. 493-497
Authors:
Yarnell, JWG
Patterson, CC
Thomas, HF
Sweetnam, PM
Citation: Jwg. Yarnell et al., Comparison of weight in middle age, weight at 18 years, and weight change between, in predicting subsequent 14 year mortality and coronary events: Caerphilly Prospective Study, J EPIDEM C, 54(5), 2000, pp. 344-348
Authors:
Sweetnam, PM
Bolton, CH
Downs, LG
Durrington, PN
Mackness, MI
Elwood, PC
Yarnell, JWG
Citation: Pm. Sweetnam et al., Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study, EUR J CL IN, 30(11), 2000, pp. 947-956
Authors:
Yarnell, JWG
Patterson, CC
Thomas, HF
Sweetnam, PM
Citation: Jwg. Yarnell et al., Fasting plasma glucose and subsequent macrovascular disease after 10 yearsfollow-up: a collaborative study on two populations, QJM-MON J A, 92(4), 1999, pp. 207-210
Authors:
Harmon, DL
Shields, DC
Woodside, JV
McMaster, D
Yarnell, JWG
Young, IS
Peng, K
Shane, B
Evans, AE
Whitehead, AS
Citation: Dl. Harmon et al., Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations, GENET EPID, 17(4), 1999, pp. 298-309
Authors:
Woodside, JV
Young, IS
Yarnell, JWG
Roxborough, HE
McMaster, D
McCrum, EE
Gey, KF
Evans, A
Citation: Jv. Woodside et al., Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial, ATHEROSCLER, 144(2), 1999, pp. 419-427
Authors:
Rumley, A
Lowe, GDO
Sweetnam, PM
Yarnell, JWG
Ford, RP
Citation: A. Rumley et al., Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study, BR J HAEM, 105(1), 1999, pp. 110-116
Authors:
Woodside, JV
Young, IS
Yarnell, JWG
McMaster, D
Patterson, CC
McCrum, EE
Evans, A
Gey, KF
Harmon, DL
Whitehead, AS
Citation: Jv. Woodside et al., Effects of folic acid on homocysteine in persons classified by methylenetetrahydrofolate reductase genotype - Reply, AM J CLIN N, 69(6), 1999, pp. 1288-1289